Felipe Nor

Dr. Felipe Nor

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2021 in Archives of Oral Biology
Verified
Journal Article
Closed access
FNFelipe Nor
Felipe Nor
CNCarolina Nör
Carolina Nör
LBLetícia W. Bento
Letícia W. Bento
ZZZhaocheng Zhang
Zhaocheng Zhang
WBWalter A. Bretz
Walter A. Bretz
JNJacques E. Nör
Jacques E. Nör

10 April 2023 in Diseases
Verified
Journal Article
Open access
PDF file
MPMaria Carolina Pinto Pereira
Maria Carolina Pinto Pereira
Juliana FernandesJuliana Fernandes
Juliana Fernandes
Gustavo FernandesGustavo Fernandes
Gustavo Fernandes
FNFelipe Nor
Felipe Nor
TMTiago Marques
Tiago Marques
PCPatrícia Couto
Patrícia Couto
Introduction: The COVID-19 pandemic has significantly impacted all public life and the global economy. Since its discovery, the disease has spread rapidly, which led to an unprecedented public health crisis and the adoption of extreme measures to limit community and hospital spread. As a result of a confluence of extraordinary circumstances caused by this pandemic, the doctrines of treatment for patients with head and neck carcinoma had to be reanalyzed, guaranteeing the well-being of both patients and health professionals as well as society itself. Objective: The aim of our systematic review was to study the impact of the COVID-19 pandemic period on head and neck cancer patients, the effects on the health care provided and on patient health. Materials and Methods: This systematic review was based on the PRISMA guidelines and PICO strategy, with the focus question, “How has the COVID-19 pandemic period conditioned the treatment of patients with head and neck carcinoma?” Thus, electronic research was carried out on six databases: LILACS, PubMed/MedLine, Web of Science, the Cochrane COVID-19 Study Register, Scielo, and Scopus, aiming to answer the research question by considering the objective and defined criteria. The following information was extracted: author and year of the publication, patients’ age, gender, time until the first appointment, time from the first appointment to the surgery, the period in the hospital, time in intensive care, TNM, general stage of cancer, diagnostic procedures, oncological procedures, reconstructive surgery, and postoperative complications. Results: Initially, 837 articles were found. After removing duplicates, we obtained 471 studies. After screening by title and abstract, 67 articles were selected for full-text reading (k = 92) in order to assess their eligibility. Thus, nine articles were included (k = 1.0). All data and statistical results were obtained and contrasted. The included studies made it possible to reveal distinct impacts felt in different institutions of several countries, not allowing generalizable conclusions to be drawn. However, some of the variables analyzed are worrying, namely, the limitations that occurred in some types of oncological surgeries, as well as the increase in the number of patients admitted with higher TNM classifications and more debilitated general conditions. Conclusion: Within the limitation of this review, the results showed efforts made to prevent the pandemic from affecting the healthcare provided. There were no significant differences in days inside the intensive care unit, postoperative complications, and, in most cases, length of stay in the hospital. There were no differences in the number of patients admitted with a history of recurrence or neoadjuvant treatment. However, some variables raise concerns, such as the increase in patients with more advanced stage and TNM classification and a decrease in certain oncological procedures.

10 January 2023 in The American Journal of Dermatopathology
Verified
Journal Article
Closed access
FNFelipe Nor
Felipe Nor
JCJuan Pablo Dds Castro
Juan Pablo Dds Castro
WWWattawan Dds Wongpattaraworakul
Wattawan Dds Wongpattaraworakul
JBJohn M. Buatti
John M. Buatti
DGDavid Gordon
David Gordon
MSMary Stone
Mary Stone
Rhabdomyosarcoma (RMS) is one of the most common soft tissue sarcomas in children. This lesion is classically included in the generic group of “small round blue cell tumors” along with other entities that share similar microscopic features. Although the head and neck region is a frequent site for primary tumors, cutaneous metastases of RMS involving this anatomical location are rare in the pediatric population. We report a case of a 12-year old girl previously diagnosed with a primary alveolar RMS involving the left maxillary sinus, presenting with a metastatic lesion on the skin of the left temple area. Along with a brief review of the previous case reports on the topic, we highlight the initial immunohistochemistry panel useful for diagnosing this tumor.

4 December 2024 in Clinical Advances in Periodontics
Verified
Journal Article
Open access
YAYousef Taha Y. Amrou
Yousef Taha Y. Amrou
AKAnass M. Koleilat
Anass M. Koleilat
Abdusalam Elmahdi AlrmaliAbdusalam Elmahdi Alrmali
Abdusalam Elmahdi Alrmali
FNFelipe Nor
Felipe Nor
Hom-Lay WangHom-Lay Wang
Hom-Lay Wang
Background: Fibrous dysplasia is generally rare, and even rarer in older adults. Special care is needed when altering the alveolar bone in these cases, especially if an implant is involved. This case study highlights such a scenario. Methods: This case study details the experience of a 63‐year‐old African American female who presented with a bump on her jaw, ultimately leading to a diagnosis of fibrous dysplasia. The patient underwent surgery for osseous recontouring to address the bone overgrowth associated with the condition. Results: The study documents the successful surgical recontouring of a fibrous dysplasia lesion in the upper right maxilla that developed 5 years after dental implant placement. Additionally, it highlights the preservation of peri‐implant hard and soft tissues over a 6‐month follow‐up period post‐surgery, ensuring proper tissue healing and bone shaping for optimal patient outcomes. Conclusion: The successful surgical recontouring of fibrous dysplasia in the upper right maxilla, along with the preservation of peri‐implant hard and soft tissues, underscores the potential for effective oral rehabilitation in similar cases involving dental implants. Key points: Why is this case new information? This case is rare because it presents a successful management strategy for fibrous dysplasia in the maxilla with dental implants, a combination that is both uncommon and challenging. What are the keys to the successful management of this case? Successful management relies on accurate diagnosis, careful surgical recontouring to preserve peri‐implant bone while providing a maintainable environment for the patient, and thorough postoperative care to ensure healing and stability. What are the primary limitations to success in this case? Primary limitations include the risk of implant compromise, potential recurrence of fibrous dysplasia, and challenges related to bone quality and healing, particularly in an older patient. Plain language summary: In this study, we managed a rare bone disorder called fibrous dysplasia in a 63‐year‐old woman, 5 years after she had dental implants in her upper jaw. This condition leads to bone overgrowth and deformities, making oral rehabilitation challenging. The patient presented with a bump in her upper jaw, which was diagnosed through various tests. We performed surgery to reshape the overgrown bone while preserving her dental implants and surrounding tissues. The surgery was successful, and 6 months later, the implants remained stable with no signs of recurring issues.

14 July 2026 in Cancer Research
Verified
Journal Article
Closed access
HTHülya Taner
Hülya Taner
WGWang Gong
Wang Gong
ELEmily A. Lanzel
Emily A. Lanzel
KDKala Chand Debnath
Kala Chand Debnath
FNFelipe Nor
Felipe Nor
YLYu L. Lei
Yu L. Lei
Head and neck squamous cell carcinomas (HNSCC) are preceded by potentially malignant precursor lesions, highlighting the need for strategies to discern which precancerous lesions harbor a high risk for malignant transformation. In this study, we developed a unique genetically engineered mouse model by inducing oral epithelial cell–specific amplification of Sox2, which recapitulates the malignant transformation of epithelial dysplasia to HNSCC with high histologic and phenotypic resemblance to human tumors. SOX2 promoted the release of IL-1α and CCL2, expanding inflammatory monocytes. The recruited myeloid cells exhibited a distinct, early, high-risk signature of high levels of IL-1α, solute carrier family 2 member 1 (SLC2A1), secreted phosphoprotein 1 (SPP1), and low levels of type I interferon (IFN-I) targets, and intralesional SLC2A1high myeloid cells were more suppressive than their SLC2A1low counterparts. Brief priming of myeloid cells with IL-1α desensitized them to stimulator of IFN genes (STING) agonists and enhanced the suppressive effects of myeloid-derived suppressor cells on T-cell activation. Mechanistically, IL-1 activation repressed the expression of DHHC3/7 enzymes that palmitoylate STING. Early blockade of IL-1 signaling using pharmacologic and genetic approaches similarly reduced the most suppressive subsets of myeloid cells, promoted immune surveillance against the progression of epithelial dysplasia, and extended survival. This work establishes a central high-risk myeloid cell transcriptomic program, characterized by elevated levels of IL-1α, SLC2A1, and SPP1, that leads to irreversible immune escape upon transformation of precancerous epithelial lesions. Significance: SLC2A1highSPP1highIFNlow myeloid cells are a central feature of high-risk epithelial premalignancy that are induced by SOX2 activity in epithelial cells and can be inhibited by targeting IL-1 signaling to inhibit tumorigenesis.

1 January 2026 in Brazilian Oral Research
Verified
Journal Article
Open access
VKValesca Koth
Valesca Koth
AGAmanda de Farias Gabriel
Amanda de Farias Gabriel
IDIohanna Deckmann
Iohanna Deckmann
RCRogerio Castilho
Rogerio Castilho
FNFelipe Nor
Felipe Nor
MMManoela Domingues Martins
Manoela Domingues Martins
This review synthesizes current literature on laser applications in dentistry, with particular emphasis on the biological mechanisms of photobiomodulation (PBM), dosimetric considerations, tissue interactions, and the clinical management of the most prevalent oral lesions. The oral disorders most frequently investigated for the therapeutic use of PBM were: a) oral pain conditions: trigeminal neuralgia, temporomandibular disorders, and burning mouth syndrome; b) oncology-related conditions: oral mucositis and hyposalivation; c) immune-mediated disorders: recurrent aphthous stomatitis and oral lichen planus; and d) viral infections: herpes labialis. A wide range of laser parameters has shown clinical benefits in the treatment of these disorders. These outcomes are attributed to the anti-inflammatory, analgesic, and tissue repair effects of PBM, which may occur immediately and cumulatively over repeated sessions. PBM therapy is a valuable therapeutic resource in contemporary dentistry and may be successfully applied in a wide range of clinical conditions. Clinical effectiveness of PBM depends on appropriate dosimetry and irradiation parameters according to the biological characteristics of each condition and therapeutic target. Therefore further well-designed randomized clinical trials and protocol standardization are still required to strengthen clinical recommendations and optimize reproducibility.